
Day 3 Recap: South Beach Symposium 2026
Key Takeaways
- Mechanism-based strategies for chronic seborrheic dermatitis prioritized long-term safety and maintenance over episodic escalation.
- Pediatric skin care recommendations favored simplified routines, with specific warnings about potentially harmful “tween” trends and overuse of actives.
Catch up on coverage from the third day of South Beach Symposium 2026.
To stay informed with the latest conference insights, follow us on social media and
Chronic SD Requires Mechanism-Based Management
At South Beach Symposium 2026, Benjamin Ungar, MD, discussed safer, long-term approaches for seborrheic dermatitis.
Less Is More: A Practical Approach to Tween Skin Care
At MOPD 2026, Lisa Swanson, MD, urges fungal cultures amid terbinafine resistance and warns attendees about risky kids’ skin care trends.
Rethinking Menopause-Related Skin Changes in Clinical Practice
Glynis Ablon, MD, FAAD, examines the intersection of menopause, hormones, and dermatologic health.
Mona Shahriari, MD, FAAD, on OX40-Targeted Therapy in AD
At South Beach Symposium 2026, Mona Shahriari explores OX40/OX40L therapies for atopic dermatitis.
GLP-1s and Skin Health: Clinical Pearls From Gold and Lal
GLP-1 therapies represent a paradigm shift requiring dermatology to integrate metabolic, medical, and aesthetic care.
For more insights from SBS and beyond, check out our
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.











